Premature ventricular contraction history and symptoms: Difference between revisions
Homa Najafi (talk | contribs) |
Homa Najafi (talk | contribs) |
||
Line 46: | Line 46: | ||
* Syncope | * Syncope | ||
* Hypotension | * Hypotension | ||
==2013 ESC Guideline for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death - Myocarditis, Rheumatic Disease, and Endocarditis<ref name="PrioriBlomström-Lundqvist2015">{{cite journal|last1=Priori|first1=Silvia G.|last2=Blomström-Lundqvist|first2=Carina|last3=Mazzanti|first3=Andrea|last4=Blom|first4=Nico|last5=Borggrefe|first5=Martin|last6=Camm|first6=John|last7=Elliott|first7=Perry Mark|last8=Fitzsimons|first8=Donna|last9=Hatala|first9=Robert|last10=Hindricks|first10=Gerhard|last11=Kirchhof|first11=Paulus|last12=Kjeldsen|first12=Keld|last13=Kuck|first13=Karl-Heinz|last14=Hernandez-Madrid|first14=Antonio|last15=Nikolaou|first15=Nikolaos|last16=Norekvål|first16=Tone M.|last17=Spaulding|first17=Christian|last18=Van Veldhuisen|first18=Dirk J.|title=2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death|journal=European Heart Journal|volume=36|issue=41|year=2015|pages=2793–2867|issn=0195-668X|doi=10.1093/eurheartj/ehv316}}</ref>== | |||
{|class="wikitable" | |||
|- | |||
| colspan="1" style="text-align:center; background:LightGreen"|[[ACC AHA Guidelines Classification Scheme#Classification of Recommendations|Class I]] | |||
|- | |||
| bgcolor="LightGreen"| <nowiki></nowiki> '''1.''' It is recommended that [[patients]] with a life-threatening presentation of [[Sustained ventricular tachycardia|sustained ventricular tachyarrhythmias]] in the context of clinically suspected myocarditis are referred to specialized centers with the ability to perform [[hemodynamic]] monitoring, [[cardiac catheterization]] and [[endomyocardial biopsy]] and to use mechanical [[cardio]]-[[pulmonary]] assist devices and specialized [[arrhythmia]] [[Therapy|therapies]]. ''([[ACC AHA Guidelines Classification Scheme#Level of Evidence|Level of Evidence: C]])''<ref name="CaforioPankuweit2013">{{cite journal|last1=Caforio|first1=A. L. P.|last2=Pankuweit|first2=S.|last3=Arbustini|first3=E.|last4=Basso|first4=C.|last5=Gimeno-Blanes|first5=J.|last6=Felix|first6=S. B.|last7=Fu|first7=M.|last8=Helio|first8=T.|last9=Heymans|first9=S.|last10=Jahns|first10=R.|last11=Klingel|first11=K.|last12=Linhart|first12=A.|last13=Maisch|first13=B.|last14=McKenna|first14=W.|last15=Mogensen|first15=J.|last16=Pinto|first16=Y. M.|last17=Ristic|first17=A.|last18=Schultheiss|first18=H.-P.|last19=Seggewiss|first19=H.|last20=Tavazzi|first20=L.|last21=Thiene|first21=G.|last22=Yilmaz|first22=A.|last23=Charron|first23=P.|last24=Elliott|first24=P. M.|title=Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases|journal=European Heart Journal|volume=34|issue=33|year=2013|pages=2636–2648|issn=0195-668X|doi=10.1093/eurheartj/eht210}}</ref><ref>{{Cite journal | |||
| title = Guidelines for diagnosis and treatment of myocarditis (JCS 2009): digest version | |||
| journal = [[Circulation journal : official journal of the Japanese Circulation Society]] | |||
| volume = 75 | |||
| issue = 3 | |||
| pages = 734–743 | |||
| year = 2011 | |||
| month = | |||
| doi = 10.1253/circj.cj-88-0008 | |||
| pmid = 21304213 | |||
}}</ref><ref>{{Cite journal | |||
| author = [[Naoyoshi Aoyama]], [[Tohru Izumi]], [[Katsuhiko Hiramori]], [[Mitsuaki Isobe]], [[Masatoshi Kawana]], [[Michiaki Hiroe]], [[Hitoshi Hishida]], [[Yasushi Kitaura]] & [[Tsutomu Imaizumi]] | |||
| title = National survey of fulminant myocarditis in Japan: therapeutic guidelines and long-term prognosis of using percutaneous cardiopulmonary support for fulminant myocarditis (special report from a scientific committee) | |||
| journal = [[Circulation journal : official journal of the Japanese Circulation Society]] | |||
| volume = 66 | |||
| issue = 2 | |||
| pages = 133–144 | |||
| year = 2002 | |||
| month = February | |||
| doi = 10.1253/circj.66.133 | |||
| pmid = 11999637 | |||
}}</ref><ref name="LibermanAnderson2014">{{cite journal|last1=Liberman|first1=Leonardo|last2=Anderson|first2=Brett|last3=Silver|first3=Eric S.|last4=Singh|first4=Rakesh|last5=Richmond|first5=Marc E.|title=INCIDENCE AND CHARACTERISTICS OF ARRHYTHMIAS IN PEDIATRIC PATIENTS WITH MYOCARDITIS: A MULTICENTER STUDY|journal=Journal of the American College of Cardiology|volume=63|issue=12|year=2014|pages=A483|issn=07351097|doi=10.1016/S0735-1097(14)60483-6}}</ref><nowiki></nowiki> | |||
|- | |||
| bgcolor="LightGreen"| <nowiki></nowiki> '''2.''' [[Temporary cardiac pacing|Temporary pacemaker]] [[insertion]] is recommended in [[patients]] with [[bradycardia]] and/or [[heart block]] triggering VA during the [[acute]] phase of myocarditis/pancarditis.''([[ACC AHA Guidelines Classification Scheme#Level of Evidence|Level of Evidence: C]])<ref name="CaforioPankuweit2013">{{cite journal|last1=Caforio|first1=A. L. P.|last2=Pankuweit|first2=S.|last3=Arbustini|first3=E.|last4=Basso|first4=C.|last5=Gimeno-Blanes|first5=J.|last6=Felix|first6=S. B.|last7=Fu|first7=M.|last8=Helio|first8=T.|last9=Heymans|first9=S.|last10=Jahns|first10=R.|last11=Klingel|first11=K.|last12=Linhart|first12=A.|last13=Maisch|first13=B.|last14=McKenna|first14=W.|last15=Mogensen|first15=J.|last16=Pinto|first16=Y. M.|last17=Ristic|first17=A.|last18=Schultheiss|first18=H.-P.|last19=Seggewiss|first19=H.|last20=Tavazzi|first20=L.|last21=Thiene|first21=G.|last22=Yilmaz|first22=A.|last23=Charron|first23=P.|last24=Elliott|first24=P. M.|title=Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases|journal=European Heart Journal|volume=34|issue=33|year=2013|pages=2636–2648|issn=0195-668X|doi=10.1093/eurheartj/eht210}}</ref><ref>{{Cite journal | |||
| title = Guidelines for diagnosis and treatment of myocarditis (JCS 2009): digest version | |||
| journal = [[Circulation journal : official journal of the Japanese Circulation Society]] | |||
| volume = 75 | |||
| issue = 3 | |||
| pages = 734–743 | |||
| year = 2011 | |||
| month = | |||
| doi = 10.1253/circj.cj-88-0008 | |||
| pmid = 21304213 | |||
}}</ref>''<nowiki></nowiki> | |||
|} | |||
==References== | ==References== |
Revision as of 22:26, 15 April 2020
Premature ventricular contraction Microchapters |
Differentiating Premature Ventricular Contraction from other Disorders |
---|
Diagnosis |
Treatment |
Case Studies |
Premature ventricular contraction history and symptoms On the Web |
FDA on Premature ventricular contraction history and symptoms |
CDC onPremature ventricular contraction history and symptoms |
Premature ventricular contraction history and symptoms in the news |
Blogs on Premature ventricular contraction history and symptoms |
to Hospitals Treating Premature ventricular contraction history and symptoms |
Risk calculators and risk factors for Premature ventricular contraction history and symptoms |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mugilan Poongkunran M.B.B.S [2]
Overview
Premature ventricular contraction patients may have no symptom at all or may present with exercise intolerance and chest pain. Sometimes patients may present with a non specific feeling of forceful beat which might need the use of Holter monitor to pick up PVCs.
History and Symptoms
Although there are many signs and symptoms associated with PVCs, PVCs may have no symptom at all. An isolated PVC is hard to catch without the use of a Holter monitor. PVCs may be perceived as a skipped heart beat, a strong beat, or a feeling of suction in the chest. They may also cause chest pain, a faint feeling, fatigue, or hyperventilation after exercise. Several PVCs in a row becomes a form of ventricular tachycardia (VT), which is a potentially fatal cardiac arrhythmia.
Some other possible symptoms of PVCs:
- Shortness of breath
- Dizziness
- Feeling your heart beat (palpitations)
- Feeling of occasional, forceful beats
- Increased awareness of your heart beat
Overview
The majority of patients with [disease name] are asymptomatic.
OR
The hallmark of [disease name] is [finding]. A positive history of [finding 1] and [finding 2] is suggestive of [disease name]. The most common symptoms of [disease name] include [symptom 1], [symptom 2], and [symptom 3]. Common symptoms of [disease] include [symptom 1], [symptom 2], and [symptom 3]. Less common symptoms of [disease name] include [symptom 1], [symptom 2], and [symptom 3].
History and Symptoms
- The majority of patients with PVC are asymptomatic.
History
Patients with [disease name]] may have a positive history of:
- [History finding 1]
- [History finding 2]
- [History finding 3]
Common Symptoms
Common symptoms of PVCs include:
- Irregular heart beats sensation (skipped heart beat, a strong beat, or a feeling of suction in the chest)
- Dizziness
- Chest pain
- Faint
- Fatigue
- Other symptoms of heart failure
Less Common Symptoms
Less common symptoms of [disease name] include
- Syncope
- Hypotension
2013 ESC Guideline for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death - Myocarditis, Rheumatic Disease, and Endocarditis[1]
Class I |
1. It is recommended that patients with a life-threatening presentation of sustained ventricular tachyarrhythmias in the context of clinically suspected myocarditis are referred to specialized centers with the ability to perform hemodynamic monitoring, cardiac catheterization and endomyocardial biopsy and to use mechanical cardio-pulmonary assist devices and specialized arrhythmia therapies. (Level of Evidence: C)[2][3][4][5] |
2. Temporary pacemaker insertion is recommended in patients with bradycardia and/or heart block triggering VA during the acute phase of myocarditis/pancarditis.(Level of Evidence: C)[2][6] |
References
- ↑ Priori, Silvia G.; Blomström-Lundqvist, Carina; Mazzanti, Andrea; Blom, Nico; Borggrefe, Martin; Camm, John; Elliott, Perry Mark; Fitzsimons, Donna; Hatala, Robert; Hindricks, Gerhard; Kirchhof, Paulus; Kjeldsen, Keld; Kuck, Karl-Heinz; Hernandez-Madrid, Antonio; Nikolaou, Nikolaos; Norekvål, Tone M.; Spaulding, Christian; Van Veldhuisen, Dirk J. (2015). "2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death". European Heart Journal. 36 (41): 2793–2867. doi:10.1093/eurheartj/ehv316. ISSN 0195-668X.
- ↑ 2.0 2.1 Caforio, A. L. P.; Pankuweit, S.; Arbustini, E.; Basso, C.; Gimeno-Blanes, J.; Felix, S. B.; Fu, M.; Helio, T.; Heymans, S.; Jahns, R.; Klingel, K.; Linhart, A.; Maisch, B.; McKenna, W.; Mogensen, J.; Pinto, Y. M.; Ristic, A.; Schultheiss, H.-P.; Seggewiss, H.; Tavazzi, L.; Thiene, G.; Yilmaz, A.; Charron, P.; Elliott, P. M. (2013). "Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases". European Heart Journal. 34 (33): 2636–2648. doi:10.1093/eurheartj/eht210. ISSN 0195-668X.
- ↑ "Guidelines for diagnosis and treatment of myocarditis (JCS 2009): digest version". Circulation journal : official journal of the Japanese Circulation Society. 75 (3): 734–743. 2011. doi:10.1253/circj.cj-88-0008. PMID 21304213.
- ↑ Naoyoshi Aoyama, Tohru Izumi, Katsuhiko Hiramori, Mitsuaki Isobe, Masatoshi Kawana, Michiaki Hiroe, Hitoshi Hishida, Yasushi Kitaura & Tsutomu Imaizumi (2002). "National survey of fulminant myocarditis in Japan: therapeutic guidelines and long-term prognosis of using percutaneous cardiopulmonary support for fulminant myocarditis (special report from a scientific committee)". Circulation journal : official journal of the Japanese Circulation Society. 66 (2): 133–144. doi:10.1253/circj.66.133. PMID 11999637. Unknown parameter
|month=
ignored (help) - ↑ Liberman, Leonardo; Anderson, Brett; Silver, Eric S.; Singh, Rakesh; Richmond, Marc E. (2014). "INCIDENCE AND CHARACTERISTICS OF ARRHYTHMIAS IN PEDIATRIC PATIENTS WITH MYOCARDITIS: A MULTICENTER STUDY". Journal of the American College of Cardiology. 63 (12): A483. doi:10.1016/S0735-1097(14)60483-6. ISSN 0735-1097.
- ↑ "Guidelines for diagnosis and treatment of myocarditis (JCS 2009): digest version". Circulation journal : official journal of the Japanese Circulation Society. 75 (3): 734–743. 2011. doi:10.1253/circj.cj-88-0008. PMID 21304213.